Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tinoridine SCHEMBL217049 | 0.99 | ADORA1 (0.98) | ADORA1LMNAMEN1MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL10855850 | 0.92 | ADORA1 (0.84) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL14234268 | 0.92 | ADORA1 (0.84) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL6993570 | 0.92 | ADORA1 (0.84) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL7719502 | 0.91 | ADORA1 (0.83) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL6992518 | 0.90 | ADORA1 (0.81) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL6993515 | 0.90 | GAA (1.00) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL16007300 | 0.89 | ADORA1 (0.80) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL7719431 | 0.88 | GAA (0.89) | ADORA1LMNAMEN1MAPTKMT2A | |
| SCHEMBL7089989 | 0.87 | GAA (0.87) | ADORA1LMNAMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3524 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12226549-B2 | Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields | ALTERGON S.A. (CH) | 2025-02-18 | — | — | US | claimed |
| WO-2024105529-A1 | CHEMICAL DISBUDDING OF LIVESTOCK | MASSEY UNIVERSITY (NZ) | 2024-05-23 | — | — | WO | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| EP-3829643-B1 | SYNERGISTICALLY COOPERATIVE COMPOSITIONS USEFUL FOR SOFT TISSUE AUGMENTATION, DRUG DELIVERY AND RELATED FIELDS | ALTERGON SA (CH) | 2023-08-30 | — | — | EP | claimed |
| EP-3998932-A1 | ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS | Parsons, C. Lowell (US) | 2022-05-25 | — | — | EP | claimed |
| US-20220118155-A1 | SYNERGISTICALLY COOPERATIVE COMPOSITIONS USEFUL FOR SOFT TISSUE AUGMENTATION, DRUG DELIVERY AND RELATED FIELDS | ALTERGON S.A. (CH) | 2022-04-21 | — | — | US | claimed |
| US-20220096498-A1 | INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION | FORDOZ PHARMA CORP. (US) | 2022-03-31 | — | — | US | claimed |
| EP-3829643-A1 | SYNERGISTICALLY COOPERATIVE COMPOSITIONS USEFUL FOR SOFT TISSUE AUGMENTATION, DRUG DELIVERY AND RELATED FIELDS | Altergon S.a. (CH) | 2021-06-09 | — | — | EP | claimed |
| US-20210145763-A1 | LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE | EYE CO PTY LTD. (AU) | 2021-05-20 | — | — | US | claimed |
| EP-3773651-A1 | LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE | Eye Co Pty Ltd. (AU) | 2021-02-17 | — | — | EP | claimed |
| US-5552160-A | NONSTEROID ANALGESICS FOR REDUCED GASTRIC IRRITATION | NANOSYSTEMS L.L.C. (US) | 1996-09-03 | — | — | US | claimed |
| WO-1996024336-A1 | NSAID NANOPARTICLES | NANOSYSTEMS L.L.C. (US) | 1996-08-15 | — | — | WO | claimed |
| WO-1996024339-A1 | COMPOSITIONS COMPRISING NANOPARTICLES OF NSAID | NANOSYSTEMS L.L.C. (US) | 1996-08-15 | — | — | WO | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| US-5518738-A | NONSTEROIDAL ANTIINFLAMMATORY AGENTS, REDUCED GASTRIC IRRITATION | NANOSYSTEM L.L.C. (US) | 1996-05-21 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| EP-0644755-A1 | SURFACE MODIFIED NSAID NANOPARTICLES. | EASTMAN KODAK CO (US) | 1995-03-29 | — | — | EP | claimed |
| WO-1993025190-A1 | SURFACE MODIFIED NSAID NANOPARTICLES | EASTMAN KODAK COMPANY (US) | 1993-12-23 | — | — | WO | claimed |